To study the effects of BET inhibition, malignant cells were purified from the peripheral blood of 12 CTCL patients (Table 1) and exposed to JQ1 in vitro. The gene discussed is DNER; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.